GlobeNewswire

MiNK Therapeutics Reports Third Quarter 2026 Results, First Pre-Commercial Product Revenue from agenT-797, Randomized ARDS Trial Advancing, and ARPA-H Selection for Deployable Cell Therapies
11/11/2026
Patients with serious unmet medical need access agenT-797 through physician-requested named-patient access; generating the Company’s first product revenue Selected as the cell therapy for the Draper-led team in ARPA-H’s [...]
Dyne Therapeutics to Participate in Upcoming Investor Conference
11/11/2026
WALTHAM, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results
11/11/2026
D-PLEX₁₀₀ NDA Under FDA Priority Review with PDUFA Goal Date of November 28, 2026; U.S. Commercial Launch Preparations Ongoing Expanding D-PLEX₁₀₀ Globally: MAA Submitted and Validated by the EMA and European [...]
BridgeBio to Present New Acoramidis Data on Kidney Function, Real-World Outcomes, and First-Line Treatment Patterns in ATTR-CM at the International Symposium on Amyloidosis 2026
11/11/2026
PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on developing medicines for [...]
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
11/11/2026
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lycia Therapeutics, Inc. (Nasdaq: LYCA), a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to [...]
Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030
11/11/2026
The Company has more than doubled revenue from innovative medicines since launching Pivot to Growth in 2023, demonstrating sustained execution and the growing strength of its high-velocity biopharma model A live webcast [...]
Applied Biologics Announces Research Collaboration with Dartmouth College Focused on Computational Protein Engineering
11/11/2026
Formal collaboration with Dartmouth’s Thayer School of Engineering will advance computationally guided therapeutic protein design supporting Applied Biologics’ gene therapy development programs SCOTTSDALE, Ariz., Nov. [...]
The savings that cost more: new report puts a number on Europe's innovation choice
11/11/2026
This release is intended for the general public , healthcare professionals, policymakers and other healthcare decision-makers , plus pharmaceutical, policy and trade media. New analysis of five EU countries as well as [...]
Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care
11/11/2026
Bagsværd, Denmark, 11 November 2026 – Novo Nordisk today announced a USD 200 million commitment to the World Diabetes Foundation (WDF) for 2027–2036. Announced ahead of World Diabetes Day (14 November), the funding will [...]
Devia Emerges from Stealth with an Agentic AI for GxP Pharma Quality Management
11/11/2026
After a year of building with manufacturing and quality teams, Devia spins out of Visium and is now available to the world’s largest biopharma companies, CDMOs and CROs, so every deviation gets solved once, not closed [...]
Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London
11/11/2026
Leiden, the Netherlands, November 11, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the 2026 Jefferies Global Healthcare Conference in London, United Kingdom, on November [...]
Onco-Innovations Announces Agreement to Terminate Performance-Based Funding Arrangement with Sorbie
11/11/2026
VANCOUVER, British Columbia, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Onco-Innovations Limited (CBOE: ONCO ) (“ Onco ” or the “ Company ”) announces that it has entered into a termination agreement (the “ Termination Agreement [...]
Neuronetics Announces Pricing of $30 Million Underwritten Public Offering of Common Stock
11/11/2026
MALVERN, Pa., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”) today announced the pricing of its previously announced underwritten public offering of its common stock, comprised of 18, [...]
Prime Medicine Announces Pricing of Public Offering of Common Stock
11/11/2026
CAMBRIDGE, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced [...]
Immutep Further Expands United States Patent Estate for Efti-Based Combination Therapies
11/11/2026
SYDNEY, AUSTRALIA, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced the grant of a new [...]
U.S. News & World Report Names Over 100 Independently Operating Ensign Group Affiliates Among Best Nursing Homes for 2027
11/11/2026
SAN JUAN CAPISTRANO, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), which invests in facilities that provide skilled nursing and senior living services, physical, occupational and [...]
Immutep Announces Release of CTOS 2026 Abstract Reporting First Survival Data from EFTISARC-NEO
11/11/2026
First survival data from EFTISARC-NEO, released in CTOS 2026 Abstract, demonstrate encouraging preliminary long-term outcomes in patients with resectable soft tissue sarcoma (STS). With a median follow-up of 19.1 months [...]
Fibermaxxing Hits the Holiday Table: Brenda Watson’s 7 Ways to Make Stuffing Healthier
11/11/2026
TAMPA, Fla., Nov. 10, 2026 (GLOBE NEWSWIRE) -- The viral “fibermaxxing” trend is making its way to the holiday table, and digestive health expert and New York Times bestselling author Brenda Watson says traditional [...]
MediPharm Labs Expands Brazilian Business with Commercial Launch of ANVISA-Authorized Cannabis Extract Oil
11/11/2026
Product developed and manufactured by MediPharm Labs is now available by prescription through Brazilian pharmacies TORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“ [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum